Código QR

Assessment of CareStart G6PD rapid diagnostic test and CareStart G6PD biosensor in Mauritania

Abstract Background The elimination of Plasmodium vivax malaria requires 8-aminoquinolines, which are contraindicated in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency due to the risk of acute haemolytic anaemia. Several point-of-care devices have been developed to detect G6PD def...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Oum Kelthoum Mamadou Djigo, Yacoub Ould Khalef, Mohamed Salem Ould Ahmedou Salem, Nicolas Gomez, Leonardo Basco, Sébastien Briolant, Ali Ould Mohamed Salem Boukhary
Formato: Artigo
Lenguaje:Inglês
Publicado: BMC 2021-08-01
Colección:Infectious Diseases of Poverty
Materias:
Acceso en línea:https://doi.org/10.1186/s40249-021-00889-2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!